Hangzhou Qihan Biotech Co., Ltd. — Ransomware Incident Claimed by Global

Qihan Biotech is a Hangzhou‑based biotech company specializing in gene editing and cell/organ therapies. It develops immune‑privileged cells and xenogeneic organs to treat cancer and organ failure. The company aims to make these therapies accessible worldwide.

Browse the incident tracker

Read the full analysis on IntelFusions